Table 2.
Comparative analysis of clinical biochemical parameters in different groups of pediatric patients.
| Project name | Positive group | Negative group | t/z value | p value | Cholestatic group | Noncholestatic group | t/z value | p value |
|---|---|---|---|---|---|---|---|---|
| (n = 29) | (n = 27) | (n = 29) | (n = 27) | |||||
| Onset of jaundice (d) | 2.0 (1.0,2.5) | 2.0 (1.0,2.0) | −0.492 | 0.623 | 2.0 (1.0,2.0) | 2.0 (2.0,3.0) | −2.136 | 0.033* |
| Duration of jaundice (d) | 34.5 (9.3,64.5) | 37.0 (22.0,57.0) | −0.707 | 0.479 | 40.0 (14.0,72.5) | 36.0 (20.5,45.3) | −0.885 | 0.376 |
| HB (g/L) | 127.19 ± 32.48 | 126.00 ± 32.17 | 0.138 | 0.891 | 123.12 ± 35.87 | 130.37 ± 27.53 | −0.843 | 0.403 |
| TIBL (μmol/L) | 69.1 (41.6,198.2) | 127.5 (90.7,221.3) | −1.697 | 0.09 | 52.0 (34.1,122.5) | 179.1 (96.8,224.1) | −3.468 | 0.001** |
| DBIL (μmol/L) | 26.8 (18.3,56.5) | 22.1 (13.3,77.6) | −0.435 | 0.664 | 60.3 (40.6,144.7) | 16.7 (12.4,20.7) | −5.911 | 0.000** |
| IBIL (μmol/L) | 127.0 (49.6,197.4) | 153.0 (80.6,256.1) | −1.049 | 0.294 | 127.0 (43.2,231.1) | 166.3 (80.1,205.6) | −1 | 0.317 |
| TBA (μmol/L) | 141.6 (23.7,301.0) | 28.7 (11.7,383.0) | −1.14 | 0.254 | 292.0 (108.6,425.0) | 24.8 (9.6,51.0) | −4.468 | 0.000** |
| ALT(U/L) | 21.5 (12.2,147.9) | 26.7 (13.7,145.4) | −0.254 | 0.799 | 134.2 (16.1,197.1) | 15.0 (12.0,24.4) | −3.337 | 0.001** |
| AST (U/L) | 34.4 (22.5,52.2) | 35.0 (21.7,121.4) | −0.771 | 0.441 | 32.3 (13.6,127.9) | 35.0 (26.6,51.2) | −0.672 | 0.501 |
| GGT (U/L) | 136.0 (63.9,198.6) | 110.6 (34.5,226.0) | −0.517 | 0.605 | 113.0 (29.7,245.1) | 126.3 (73.4,174.0) | −0.746 | 0.456 |
Explanatory note:Hemoglobin: HB, Total Bilirubin; TIBL, Direct Bilirubin; DBIL, Indirect Bilirubin; IBIL, Total Bile acid; TBA, Glutamic-Pyruvic Transaminase; ALT, Glutamic-Oxalacetic Transaminase; AST, γ-Glutamyl Transpeptidase; GGT. *p < 0.05 **p < 0.01.